IDSA guidelines published for treating MRSA
January 6, 2011
WASHINGTON — A 13-member expert panel of the Infectious Diseases Society of America (IDSA) has published guidelines for the treatment of methicillin resistant Staphylococcus aureus (MRSA) to assist health care providers in treating adult and pediatric patients afflicted with MRSA infections, according to The Examiner.
The guidelines were published on January 4, 2011, in the journal, Clinical Infectious Diseases, the article noted.
The guideline addresses such common MRSA issues such as: The treatment of skin and soft tissue infections which are becoming a more frequent occurrence, bacteremia and endocarditis, the use of vancomycin in the treatment of MRSA infections and a plethora of other treatment and testing issues, the article stated.
According to an IDSA statement: The guidelines are voluntary and are not intended to take the place of a doctor''s judgment, but rather support the decision-making process, which must be individualized according to each patient''s circumstances.
Click here to read the complete article.